
Sign up to save your podcasts
Or


The topic of today's podcast is tenecteplase. This is a thrombolytic drug that is administered intravenously, for certain patients who present to the hospital with an acute ischemic stroke. There is mounting evidence that intravenous tenecteplase is at least as safe and effective as intravenous alteplase, the current standard of care in ischemic stroke. Tenecteplase also less expensive and easier to administer. Our guest today is Dr. Bruce Campbell, who has played a pivotal role in the deployment of tenecteplase for stroke. Dr. Campbell was interviewed by Dr. Michelle Johansen, a vascular neurologist at Johns Hopkins. Series 2, Episode 5
By American Neurological Association4.8
99 ratings
The topic of today's podcast is tenecteplase. This is a thrombolytic drug that is administered intravenously, for certain patients who present to the hospital with an acute ischemic stroke. There is mounting evidence that intravenous tenecteplase is at least as safe and effective as intravenous alteplase, the current standard of care in ischemic stroke. Tenecteplase also less expensive and easier to administer. Our guest today is Dr. Bruce Campbell, who has played a pivotal role in the deployment of tenecteplase for stroke. Dr. Campbell was interviewed by Dr. Michelle Johansen, a vascular neurologist at Johns Hopkins. Series 2, Episode 5

32,243 Listeners

299 Listeners

53 Listeners

25 Listeners

81 Listeners

9 Listeners